f Translational Informatics for Neuropharmacology: Databases, Ontologies, and Analytics

References

1. ZhengX. ChenJ. ZhangY. HuS. BiC. SinglaR.K. KamalM.A. HorimotoK. ShenB. Translational informatics driven drug repositioning for neurodegenerative disease.Curr. Neuropharmacol.202523141841185910.2174/011570159X327908241121062335 39936420
   [Google Scholar]
2. ShenB. LinY. BiC. ZhouS. BaiZ. ZhengG. ZhouJ. Translational informatics for Parkinson’s disease: From big biomedical data to small actionable alterations.Genomics Proteomics Bioinformatics201917441542910.1016/j.gpb.2018.10.007 31786313
   [Google Scholar]
3. YuC. ZongH. ChenY. ZhouY. LiuX. LinY. LiJ. ZhengX. MinH. ShenB. PCAO2: an ontology for integration of prostate cancer associated genotypic, phenotypic and lifestyle data.Brief. Bioinform.2024253bbae13610.1093/bib/bbae136 38557678
   [Google Scholar]
4. YangH. LiJ. ZhangC. SierraA.P. ShenB. Large language model–driven knowledge graph construction in sepsis care using multicenter clinical databases: Development and usability study.J. Med. Internet Res.202527e6553710.2196/65537 40146985
   [Google Scholar]
5. TinazziM. GandolfiM. ArtusiC.A. BannisterK. RukavinaK. Brefel-CourbonC. de AndradeD.C. Perez-LloretS. MyliusV. Advances in diagnosis, classification, and management of pain in Parkinson’s disease.Lancet Neurol.202524433134710.1016/S1474‑4422(25)00033‑X 40120617
   [Google Scholar]
6. CantorM.N. Translational informatics: An industry perspective.J. Am. Med. Inform. Assoc.201219215315510.1136/amiajnl‑2011‑000588 22237867
   [Google Scholar]
7. MittalP. GautamR.K. SharmaH. GoyalR. Neural networks of knowledge: Ontologies pioneering precision medicine in neurodegenerative diseases.Curr. Neuropharmacol.2025231418781893
   [Google Scholar]
8. Bernal-VicenteB.N. PonceI. Santos-GutiérrezM. Neuroprotective proteins in hypoxia-stressed astrocyte-derived extracellular vesicles.Curr. Neuropharmacol.2025231419621978
   [Google Scholar]
9. AhmadS. WangL. ZafarI. AbbasZ. UnarA. MohanyM. Al-RejaieS.S. Ullah KhanN. AliI. ShafiqM. Informatics approach towards targeting HTR1B pathways in neuropharmacology for migraine treatment.Curr. Neuropharmacol.202523141939196110.2174/011570159X341703250130064735 39936416
   [Google Scholar]
10. GlotfeltyE.J. KarlssonT.E. Tovar-y-RomoL.B. OlsonL. HarveyB.K. GreigN.H. Analyses of Nogo-family genes in mouse and human microglia omics datasets identify LINGO1 as a candidate drug target in Alzheimer’s disease.Curr. Neuropharmacol.2025231419181938
    [Google Scholar]
11. BatoolZ. HuS.S. KamalM.A. GreigN.H. ShenB. Advancing Alzheimer’s diagnosis with AI-enhanced MRI: A review of challenges and implications.Curr. Neuropharmacol.2025231418601877
    [Google Scholar]
12. KhanK.A. EsaM. KamalZ. UllahB. PerryG. KamalS. AhmadS. HussainH. UllahA. ShafiqueM. Conventional and emerging drug targeting sites in Alzheimer’s disease and the role of translational informatics in its diagnosis and management.Curr. Neuropharmacol.202523141894191710.2174/011570159X361867250313073624 40207764
    [Google Scholar]
13. MuzafferU. GullB. AhmedZ. AhmadM. Neuropharmacological interventions of plant origin for Parkinson’s disease: A comprehensive appraisal.Curr. Neuropharmacol.2025231418161840
    [Google Scholar]